Can you share your analysis on why APT shouldn't have been valued at $10 billion prior to COVID-19?
Obviously the lack of NPAT and EPS bothers you, I just think it would be good to have discussions on your concerns regarding these metrics on analysis based on the companies financials. I'm sure you've done it because it would be hard to come to the conclusion that the business isn't worth $10b without digging into the financials and understanding, in particular, where the expenses are going to.
